11/12/2024 | Press release | Distributed by Public on 11/12/2024 15:04
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Option to Purchase Common Stock | $132.12 | 11/11/2024 | M | 17,500 | 06/07/2019 | 06/07/2025 | Common Stock | 17,500 | $ 0 | 17,500 | D | ||||
Option to Purchase Common Stock | $143.92 | 06/03/2020 | 06/03/2026 | Common Stock | 35,000 | 35,000 | D | ||||||||
Option to Purchase Common Stock | $137.44 | 06/02/2021(2) | 06/02/2027 | Common Stock | 20,743 | 20,743 | D | ||||||||
Option to Purchase Common Stock | $199.16 | 06/03/2022(3) | 06/03/2028 | Common Stock | 35,000 | 35,000 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
BERGERON DANIEL A 14 BENTAGRASS LANE NEWTOWN, CT 06470 |
X | Vice President and COO |
/s/John J. Feeney/attorney in fact | 11/12/2024 |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Includes 17,693 shares of restricted stock, which vest according to the following schedule; 3,925 shares that vest on 6/3/2025; 7,032 shares 1/2 of which vest on 6/1/2025 and 1/2 vest on 6/1/2026; and 6,736 shares 1/3 of which vest on 5/23/2025, 1/3 vest on 5/23/2026 and 1/3 vest on 5/23/2027. |
(2) | All these options to purchase Common Stock are exerciseable except for 4,149 options that vest on 6/2/2025. |
(3) | All these options to purchase Common Stock are exerciseable except for 14,000 options that are subject to the following vesting schedule - 1/2 vest on 6/3/2025 and 1/2 vest on 6/3/2026. |